Lanzamiento Enero 2027

Ensayo controlado aleatorizado2006Financiación no declarada

Phytosterols mixed with medium-chain triglycerides and high-oleic canola oil decrease plasma lipids in overweight men

Rudkowska I, Roynette CE, Nakhasi DK, Jones PJ

Metabolism: clinical and experimental · 21 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2006-02-15 · Metabolism · vol. 55 · número 3 · págs. 391–395
Editorial
Elsevier BV
Citado
30 citas · más que el 86% de estudios similares · 1.9× el promedio de su campo
Referencias
28 trabajos
Acceso
De pago
Áreas de investigación
Cholesterol and Lipid Metabolism · Lipoproteins and Cardiovascular Health · Fatty Acid Research and Health
Palabras clave
phytosterols, medium-chain triglycerides, hyperlipidemia, overweight men, plasma lipids, LDL cholesterol, total cholesterol, HDL cholesterol, triglycerides, olive oil, functional oils, weight loss, cardiovascular risk, dietary intervention, cholesterol absorption inhibition, sterol esters
MeSH
humans, cholesterol, phytosterols, lipids, fatty acids, monounsaturated, oleic acid, triglycerides, plant oils, cross-over studies, single-blind method, adolescent, adult, middle aged, male, overweight, cholesterol, ldl, hyperlipidemias, olive oil, rapeseed oil

4 autores

  • Iwona Rudkowska🇨🇦McGill University
  • Catherine E. Roynette🇨🇦McGill University
  • Dilip K. Nakhasi🇺🇸Bunge (United States)
  • Peter J.H. Jones🇨🇦 · autor de correspondenciaMcGill University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Phytosterols (PSs) have been recently added to various mediums. Nevertheless, matrices with functional properties, such as medium-chain triglycerides (MCTs), should be precisely examined for supplementary advantages. The objective of this study was to identify the existence of combined biological actions of a functional oil enriched in PSs within MCTs and high-oleic canola (HOC), relative to a control (olive oil), in overweight, hyperlipidemic men using a rigorously controlled dietary intervention. Twenty-three overweight, hyperlipidemic men consumed both types of oil in a randomized, crossover trial for 6 weeks each. Fasted plasma samples were collected on the first and last 2 days of each study period. Body weight decreased -1.22 +/- 0.35 kg (P = .0019) and -1.68 +/- 0.47 kg (P = .0016) after the 6-week study period in the olive oil and functional oil groups, respectively. The end points for total cholesterol and low-density lipoprotein cholesterol (LDL-C) in the functional oil group (P = .0006) were lower than in the olive oil group (P = .0002). Total cholesterol values decreased from comparable baseline to end point of 4.71 +/- 0.16 mmol/L (P < .0001) in the functional oil phase and 5.14 +/- 0.19 mmol/L (P = .0001) in the olive oil phase (P = .0592). In addition, LDL-C demonstrated a similar drop, to an end point of 3.12 +/- 0.16 mmol/L (P < .0001) and 3.54 +/- 0.18 mmol/L (P = .0002), for the functional oil and olive oil groups, respectively, with significant changes (P = .0221). High-density lipoprotein cholesterol levels did not change in either treatment. Triacylglycerol end points decreased in functional oil and olive oil groups (P = .0195 and .0105, respectively) to the same extent from baseline. Results indicate that PSs mixed within an MCT- and HOC-rich matrix lower plasma LDL-C, without significantly changing the high-density lipoprotein cholesterol concentrations, in hyperlipidemic, overweight men, and may therefore decrease the risk of cardiovascular events.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.